rolafagrel has been researched along with Hyperlipemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albertazzi, L; Calandra, S; Marchi, L; Nicolini, S; Salvati, P; Tarugi, P | 1 |
| Benigni, A; Bianchi, G; Braidotti, P; Duzzi, L; Ferrario, RG; Ferti, C; Lamberti, E; Perico, N; Remuzzi, G; Salvati, P | 1 |
2 other study(ies) available for rolafagrel and Hyperlipemia
| Article | Year |
|---|---|
The effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome.
Topics: Aging; Animals; Apolipoproteins A; Apolipoproteins E; Body Weight; Disease Models, Animal; Hyperlipidemias; Imidazoles; Lipid Metabolism; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Naphthalenes; Nephrotic Syndrome; Proteinuria; Rats; Rats, Inbred Strains; Thromboxane-A Synthase | 1994 |
Role of enhanced glomerular synthesis of thromboxane A2 in progressive kidney disease.
Topics: Animals; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Hypertension; Imidazoles; Kidney Glomerulus; Male; Naphthalenes; Rats; Rats, Inbred SHR; Thromboxane A2; Thromboxane-A Synthase; Time Factors | 1990 |